The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Can PSMA-PET be a better way to select patients for an intermittent treatment? Results from a prospective cohort.
 
Dr. Paulo Sergio Lages
Honoraria - Astellas Medivation; Bayer; BMS Brazil; Ipsen; Janssen Oncology; MSD Oncology
Consulting or Advisory Role - Astellas Medivation; Bayer; Janssen Oncology; Novartis
Speakers' Bureau - Astellas Medivation; Bayer; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology
 
Guilherme Augusto Zulli
No Relationships to Disclose
 
Flavio Mavignier Carcano
No Relationships to Disclose
 
Michelle Barbosa
No Relationships to Disclose
 
Luciana Lages
No Relationships to Disclose
 
Paulo Gustavo Bergerot
No Relationships to Disclose
 
Diogo Augusto Rodrigues Rosa
No Relationships to Disclose
 
Denis L. Jardim
No Relationships to Disclose
 
Mariane Fontes Dias
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; MSD Oncology; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca; Ipsen; Janssen; Merck; MSD Oncology
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ipsen; Janssen Oncology; MSD Oncology; Zodiac Pharma
Research Funding - Bayer; BMS Brazil; Janssen Research & Development
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; MSD Oncology; Zodiac Pharma
 
Luiz Flavio Penna Coutinho
No Relationships to Disclose
 
Daniel Vargas Pivato de Almeida
No Relationships to Disclose